Vireo Growth INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
Vireo Growth Inc. announced the closing of a $85 million senior secured asset-based revolving credit facility and the completion of its acquisition of PharmaCann's Colorado retail assets, expanding its dispensary footprint.
OTC.Pink
Vireo Growth Inc. announced robust second-quarter 2026 financial results, showcasing substantial year-over-year revenue growth fueled by strategic acquisitions and detailing plans for further expansion.
OTC.Pink
Vireo Growth Inc. announced four definitive agreements to acquire 100% of the membership interests of four Ohio-based cannabis companies, establishing a significant vertically integrated presence in the state.
OTC.Pink
Vireo Growth Inc. announced its entry into a definitive merger agreement to acquire Planet 13 Holdings Inc., with the transaction expected to close by July 26, 2027.
OTC.Pink
Vireo Growth Inc. announced its definitive merger agreement to acquire Planet 13 Holdings Inc., aiming to expand its multi-state cannabis operations.
OTC.Pink
Vireo Growth Inc. has entered into a definitive agreement to acquire certain cannabis operations from The Cannabist Company Holdings Inc. across five U.S. markets for up to $35 million.
OTC.Pink
Vireo Growth Inc. filed an amendment to its Form 8-K to include detailed financial statements for the acquired Hawthorne Gardening Company.
OTC.Pink
Vireo Growth Inc. has entered into a definitive agreement to acquire C21 Investments Inc. in an all-share transaction valued at an undisclosed amount, expanding Vireo's footprint in Nevada.
OTC.Pink
Vireo Growth Inc. filed an amendment to its Form 8-K to provide audited financial statements for Eaze Inc. and pro forma combined financial information following their merger.
OTC.Pink
Vireo Growth Inc. has completed the acquisition of Bridgewell Agribusiness LLC for approximately $13.66 million, funded through convertible notes, and also announced plans for dispensary acquisitions in Nevada and Maryland.
OTC.Pink
Vireo Growth Inc. is implementing a 30-for-1 share consolidation, effective June 5, 2026, to reduce its outstanding share count while maintaining shareholder ownership percentages.
OTC.Pink
Vireo Growth Inc. has transitioned its independent audit firm from Davidson & Company LLP to BDO USA, P.C. effective June 5, 2026.
OTC.Pink
Vireo Growth Inc. announced the approval of six shareholder proposals at its annual general and special meeting on May 29, 2026, including director elections and a share consolidation.
OTC.Pink
Vireo Growth Inc. has exercised its option to purchase a 389,000 square foot cannabis facility in Perth, New York, for $88.5 million.
OTC.Pink
Vireo Growth Inc. reported a 333.5% year-over-year increase in Q1 2026 GAAP revenue to $106.2 million, driven by strategic acquisitions.
OTC.Pink
Vireo Growth Inc. has completed the acquisition of The Hawthorne Gardening Company LLC from The Scotts Miracle-Gro Company, strengthening its balance sheet with approximately $110 million in cash and net working capital.
OTC.Pink
Vireo Growth Inc. has finalized its acquisition of Eaze Inc. and entered a strategic partnership to restructure its New York operations for social equity compliance.
OTC.Pink
Vireo Growth Inc. announced the effectiveness of its Management Services Agreement with PharmaCann Inc., a key step towards closing the Colorado asset acquisition expected in Q2 2026.
OTC.Pink
Vireo Growth Inc. has finalized its acquisition of 45 dispensaries and two manufacturing facilities from Schwazze, expanding its cannabis operations in Colorado and New Mexico.
OTC.Pink
Vireo Growth Inc. reported a 317.7% year-over-year GAAP revenue increase to $104.5 million in Q4 2025, driven by recent acquisitions, and announced further M&A plans.
OTC.Pink
Vireo Growth Inc. announced a definitive agreement to acquire Eaze Inc., expanding its cannabis operations into California and Florida and strengthening its Colorado presence.
OTC.Pink
Vireo Growth Inc. announced it will acquire approximately $2.6 million of Schwazze's defaulted senior secured convertible notes for $1.6 million in Vireo shares, increasing its ownership to 89%.
OTC.Pink
Vireo Growth Inc. announced an Asset Purchase Agreement to acquire certain retail assets and properties from PharmaCann Inc. in Colorado for $49 million in subordinate voting shares.
OTC.Pink
Vireo Growth Inc. secured a majority of Schwazze's assets through a $111 million credit bid, initiating a restructuring plan.
OTC.Pink
Vireo Growth Inc. reported a 264% year-over-year revenue increase to $91.7 million in Q3 2025, driven by strategic acquisitions and the launch of adult-use cannabis sales in Minnesota.
OTC.Pink
Vireo Growth Inc. announced a comprehensive settlement with Verano Holdings Corp., resolving all outstanding litigation for approximately US$10 million.
OTC.Pink
Vireo Growth Inc. has acquired a majority of Schwazze's defaulted senior secured notes and entered a restructuring agreement to acquire most of Schwazze's assets, aiming for strategic expansion.
OTC.Pink
Vireo Growth Inc. has entered into agreements to acquire approximately 86% of Schwazze's outstanding senior secured convertible notes for $62 million, paid in Vireo shares, as Schwazze is currently in default.
OTC.Pink
Vireo Growth Inc. announced second quarter 2025 financial results, reporting a 91% year-over-year GAAP revenue increase to $48.1 million, aligning with pro forma expectations following recent merger completions and a significant refinancing.
OTC.Pink
Vireo Growth Inc. completed its acquisitions of Deep Roots Holdings and Proper Companies, releasing unaudited pro forma financial information reflecting significant strategic expansion.